Russia expects 50mln doses of Sputnik V to be made in India per month this summer

Dmitriev also said manufacturing of Sputnik V would also begin in Serbia and Iran

  
A medical worker prepares a dose of the Sputnik V (Gam-COVID-Vac) vaccine against the coronavirus disease (COVID-19) in a carriage of the Academician Fyodor UglovA medical train, at a railway station in the town of Tulun in Irkutsk Region, Russia March 16, 2021.

A medical worker prepares a dose of the Sputnik V (Gam-COVID-Vac) vaccine against the coronavirus disease (COVID-19) in a carriage of the Academician Fyodor UglovA medical train, at a railway station in the town of Tulun in Irkutsk Region, Russia March 16, 2021.

Reuters/Evgeny Kozyrev

MOSCOW- Russia is expecting India to initially be making 50 million doses of its Sputnik V COVID-19 vaccine each month this summer, Kirill Dmitriev, head of Russian RDIF fund, told reporters on Tuesday.

On Monday, India, the world's second most populous nation, approved the use of Sputnik V, hailed by Dmitriev as a milestone for the vaccine.

The Russian Direct Investment Fund, which is responsible for marketing the vaccine abroad, has signed deals with six firms in India to produce more than 750 million doses of Sputnik V. 

Dmitriev also said manufacturing of Sputnik V would also begin in Serbia and Iran in the "nearest future", while production in Italy is expected in the next few months.

Sputnik V will be produced in Italy by Swiss-based pharmaceutical company Adienne Pharma & Biotech.

(Reporting by Vladimir Soldatkin; Editing by Alison Williams and Bernadette Baum) ((vladimir.soldatkin@reuters.com; +7 495 775 12 42;))

More From Life